Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

LON/0RRB stock hub

LON/0RRB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RRBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

319.4M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RRB

In the news

Latest news · LON/0RRB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-35.9

P25 -54.2P50 2.1P75 13.7

ROIC-18.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RRB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

CHF

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	1,337
Employees Change	-59%
Employees Change Percent	-3.61
Enterprise value	CHF 441.3M
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical Distribution
Isin	CH0042615283
Last refreshed	2026-05-10
Market cap	CHF 319.4M
Price	CHF 7.34
Price currency	CHF
Rev Per Employee	788,049.84x
Sector	Healthcare
Sic	5961
Symbol	lon/0RRB
Website	https://corporate.docmorris.com/en

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-39.42%
EV Earnings	-3.5x
EV/FCF	-5.21x
EV/Sales	0.42x
FCF yield	-26.51%
P/B ratio	0.83x
P/S ratio	0.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.75%
EBITDA Margin	-7.67%
Gross margin	22.23%
Gross Profit	CHF 234.2M
Gross Profit Growth	15.43%
Gross Profit Growth Q	18%
Gross Profit Growth3 Y	16%
Gross Profit Growth5 Y	0.7%
Net Income	CHF -125.9M
Net Income Growth Years	0%
Pretax Margin	-10.85%
Profit Margin	-11.95%
Profit Per Employee	CHF -94,188
ROA	-7.67
Roa5y	-7.63
ROCE	-14.24
ROE	-35.88
Roe5y	-35.31
ROIC	-18.28
Roic5y	-18.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-33.2%
Cagr3y	-25.64%
Cagr5y	-45.22%
EPS Growth Quarters	7
EPS Growth Years	4
Revenue Growth	10.56x
Revenue Growth Q	11.95x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	6.5x
Revenue Growth5 Y	-5.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 1.4
Assets	CHF 773.4M
Cash	CHF 149.4M
Current Assets	CHF 278.3M
Current Liabilities	CHF 126.9M
Debt	CHF 270.5M
Debt Equity	CHF 0.71
Debt FCF	CHF -3.19
Equity	CHF 383.3M
Interest Coverage	-5.63
Liabilities	CHF 390.1M
Long Term Assets	CHF 495.1M
Long Term Liabilities	CHF 263.2M
Net Cash	CHF -121M
Net Cash By Market Cap	CHF -37.89
Net Debt Equity	CHF 0.32
Tangible Book Value	CHF -66.7M
Tangible Book Value Per Share	CHF -1.39
WACC	9.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.19
Inventory Turnover	20.51
Net Working Capital	CHF 25.5M
Quick ratio	1.82
Working Capital	CHF 150.2M
Working Capital Turnover	CHF 8.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-228.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-33.18%
200-day SMA	6
3Y total return	-58.88%
50-day SMA	5.54
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.06%
All Time High	514
All Time High Change	-98.57%
All Time High Date	2021-02-15
All Time Low	3.92
All Time Low Change	87.26%
All Time Low Date	2026-03-24
ATR	0.32
Beta	1.63
Ch YTD	25.16
High	7.58
High52	21.41
High52 Date	2025-05-08
High52ch	-67.66%
Low	7.08
Low52	3.92
Low52 Date	2026-03-24
Low52ch	87.26%
Ma50ch	32.6%
Price vs 200-day SMA	22.32%
RSI	73.45
RSI Monthly	34.66
RSI Weekly	58.56
Sharpe ratio	-0.51x
Sortino ratio	-0.63
Total Return	-228.37%
Tr YTD	25.17
Tr1m	47.19%
Tr1w	4.05%
Tr3m	28.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF -92.2M
Operating margin	-8.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,961,916%
Net Borrowing	-32,362,397.3
Shares Insiders	3.9%
Shares Institutions	31.6%
Shares Qo Q	0%
Shares Yo Y	228.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -84.7M
Average Volume	91,528.65x
Bv Per Share	7.97
CAPEX	CHF -1.7M
Ch1m	47.19
Ch1w	4.05
Ch1y	-67.1
Ch3m	28.22
Ch3y	-79.75
Ch5y	-97.57
Ch6m	46.26
Change	-0.4%
Change From Open	-0.67
Close	7.37
Days Gap	0.27
Depreciation Amortization	11,448,956.9
Dollar Volume	514,772.2
Earnings Date	2026-08-19
EBIT	CHF -92.2M
EBITDA	CHF -80.8M
EPS	CHF -3.25
F Score	5
FCF	CHF -84.7M
FCF EV Yield	-19.19x
Financing CF	155,383,933
Fiscal Year End	December
Founded	1,993
Goodwill	340,947,990.5
Income Tax	CHF 11.6M
Investing CF	-48,830,265
Is Primary Listing	0
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Ma150	5.63
Ma150ch	30.41%
Ma20	6.8
Ma20ch	8.01%
Net CF	22,977,295
Next Earnings Date	2026-08-19
Open	7.39
Position In Range	52.11
Ppne	39,929,263.7
Price Date	2026-05-08
Relative Volume	0.8x
Revenue	1,053,622,631x
Tax By Revenue	1.1x
Tr6m	46.24%
Volume	70,127
Z Score	0.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RRB pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RRB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RRB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.6%

Share of float held by funds and institutions

Insider ownership

+3.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+228.4%

Negative means the company is buying back shares.

Technical

LON/0RRB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.4

Above 70: short-term overbought

Price vs 200-day MA

+22.3%

50/200-day relationship not available

Beta (5Y)

1.63

More volatile than the market

Sharpe ratio

-0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RRB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RRB stock rating?

lon/0RRB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RRB analysis?

The full report lives at /stocks/lon/0RRB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RRB?

The latest report frames lon/0RRB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RRB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.